Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
Background: The COVID-19 pandemic caused by the SARS-CoV-2 virus has left infected patients with comorbidities in severe and deadly conditions. Hypertension is a non-communicable disease (NCD) and is one of the most common comorbidities observed in COVID-19 patients. Purpose: This study aims to unde...
Main Authors: | Nina Widyasari, Hari Basuki, Chatarina Umbul Wahjuni |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Universitas Airlangga
2021-05-01
|
Series: | Jurnal Berkala Epidemiologi |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/JBE/article/view/26379 |
Similar Items
-
COVID-19, hypertension, and diabetes – Hunt for the link!
by: Kaustav Saha, et al.
Published: (2021-01-01) -
Prevalence, Clinical Manifestation and Mortality Rate in COVID-19 Patients With Underlying Diseases
by: Mehrdad Nasrollahzadeh Sabet, et al.
Published: (2020-11-01) -
The Relationship Between COVID-19-induced Death and Chronic Diseases
by: Hasan Alinejad, et al.
Published: (2021-08-01) -
Impact of Co-morbidities on Outcome of COVID-19 Patients: An Observational Study among Patients Admitted to Intensive Care Unit
by: Hemant Kumar, et al.
Published: (2021-07-01) -
COVID-19, hypertension, and cardiovascular disease
by: HK Chopra, et al.
Published: (2020-01-01)